Toronto Dominion Bank (TD) has made a significant move in the financial market by filing a preliminary pricing supplement for Callable Contingent Interest Barrier Notes. This filing, dated October 30, 2026, is crucial as it outlines the bank's strategy to enhance its investment offerings.
The Callable Contingent Interest Barrier Notes are linked to the performance of the Dow Jones Industrial Average, Russell 2000, and S&P 500 indices. This innovative product is designed to attract investors by offering contingent interest payments based on the performance of these major stock indices.
Background
Toronto Dominion Bank is a prominent player in the financial sector, classified under the SIC code 6029, which pertains to Commercial Banks, NEC. The bank operates on the New York Stock Exchange (NYSE) and the Over-the-Counter (OTC) market, with ticker symbols TD and TDBCP. The latest filing is part of a series of recent filings, including several other preliminary pricing supplements, all dated October 30, 2026.
What the Filing Says
The filing states, "The information in this pricing supplement is not complete and may be changed." It emphasizes that this document is not an offer to sell nor does it seek an offer to buy these notes in any state where the offer or sale is not permitted.
Furthermore, the notes will pay a contingent interest payment at an approximate rate of 8.95% per annum, contingent on the performance of the linked indices. If the closing value of any reference asset is less than its contingent interest barrier value on a specified observation date, no contingent interest payment will be made.
Impact
This offering may significantly affect investors looking for innovative financial products. The notes are unsecured and not insured by any government agency, which introduces a level of risk for potential investors. The filing also indicates that TD may elect to call the notes prior to maturity, providing flexibility in managing its liabilities.
What's Next
The filing does not specify what happens next, but it indicates that the pricing date for these notes is set for November 6, 2026, followed by the issue date on November 12, 2026. Investors and market analysts will be closely watching how this new product is received in the market.
Read Next
Mirum Pharmaceuticals reports stock sale by former officer
Basswood Financial Fund sells shares of Regional Management Corp.
Basswood Financial Fund Files to Sell Shares in Regional Management
HCA Healthcare Officer Jon M. Foster Files to Sell Shares
Regional Management Corp. Sees Shareholder Stock Sale
Wampler Kira Scherer Reports Stock Transactions for Doximity










